In vitro activities of nine peptide deformylase inhibitors and five comparator agents against respiratory and skin pathogens

International Journal of Antimicrobial Agents

Volumn 22, Issue 6, 2003, Pages 557-561

  Bowker, K E ^a   Noel, A R ^a   MacGowan, A P ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Antibacterial effect; Peptide deformylase inhibitors; Respiratory skin isolates

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; BB 84879; BB 84880; BB 84885; BB 84887; BB 85035; BB 85128; BB 85318; BB 88488; ERYTHROMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; N [1 TERT BUTYL 2 OXO 2 [4 (2 THIAZOLYLMETHYL) 1 PIPERAZINYL]ETHYL] 3 CYCLOPENTYL 2 (N FORMYL N HYDROXYAMINOMETHYL)PROPIONAMIDE; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SKIN FLORA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIA;

EID: 0344255639     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00246-2     Document Type: Article

References (3)

1. Wootton M, Howe RA, MacGowan AP, Walsh TR. In vitro activity of BB-83698 and two other peptide deformylase inhibitors compared to ciprofloxacin, moxifloxacin, gentamicin and linezolid against heterogeneous glycopeptide intermediate Staphylococcus aureus (hGISA) and GISA. Abstract F352 In Proceedings of 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago: 2001.
2. Wise R., Andrews J.M., Ashby J. In vitro activities of peptide deformylase inhibitors against gram-positive pathogens. Antimicrob. Agents Chemother. 46:2002;1117-1118.
3. National Committee for Clinical Standards. Methods for determining bactericidal activity of antimicrobial agents; approved standard. 5th ed. M7-A5 NCCLS, Villanova, PA: 2000.